Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps ...

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians ...

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.

Stopping insulin in Type 1 diabetes can rapidly trigger fatal diabetic ketoacidosis, making insulin essential for survival.

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...

Type 1 diabetes management involves monitoring blood sugar, diet, activity, and insulin treatment. Support from parents and ...

Type 1 and Type 2 diabetes share warning signs, but early diagnosis is crucial to prevent serious complications and improve ...

For actors, managing type 1 diabetes can be especially challenging. Long filming days, physically demanding scenes, delayed ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...